Stichting European Myeloma Network
Clinical trials sponsored by Stichting European Myeloma Network, explained in plain language.
-
New combo shows promise in slowing advanced myeloma
Disease control CompletedThis study tested whether adding daratumumab to two standard drugs (pomalidomide and dexamethasone) could help people with multiple myeloma that came back or didn't respond to earlier treatments. 304 adults took part. The goal was to see if the triple combination could delay canc…
Phase: PHASE3 • Sponsor: Stichting European Myeloma Network • Aim: Disease control
Last updated May 01, 2026 20:12 UTC
-
New hope for rare blood disease: experimental drug shows promise in early trial
Disease control CompletedThis study tested a drug called belantamab mafodotin in 35 adults with AL amyloidosis, a rare disease where abnormal proteins build up in organs. Participants had already tried other treatments without success. The goal was to see if the drug could reduce the abnormal protein lev…
Phase: PHASE2 • Sponsor: Stichting European Myeloma Network • Aim: Disease control
Last updated May 01, 2026 15:59 UTC